Asset Details
Do you wish to reserve the book?
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
Do you wish to request the book?
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
2009
Overview
Plasmodium vivax is geographically the most widely distributed cause of malaria in people, with up to 2·5 billion people at risk and an estimated 80 million to 300 million clinical cases every year—including severe disease and death. Despite this large burden of disease,
P vivax is overlooked and left in the shadow of the enormous problem caused by
Plasmodium falciparum in sub-Saharan Africa. The technological advances enabling the sequencing of the
P vivax genome and a recent call for worldwide malaria eradication have together placed new emphasis on the importance of addressing
P vivax as a major public health problem. However, because of this parasite's biology, it is especially difficult to interrupt the transmission of
P vivax, and experts agree that the available methods for preventing and treating infections with
P vivax are inadequate. It is thus imperative that the development of new methods and strategies become a priority. Advancing the development of such methods needs renewed emphasis on understanding the biology, pathogenesis, and epidemiology of
P vivax. This Review critically examines what is known about
P vivax, focusing on identifying the crucial gaps that create obstacles to the elimination of this parasite in human populations.
Publisher
Elsevier Ltd,Lancet Publishing Group,Elsevier Limited
Subject
/ Animals
/ Antimalarials - pharmacology
/ Antimalarials - therapeutic use
/ Biological and medical sciences
/ Humans
/ Malaria
/ Malaria, Vivax - drug therapy
/ Malaria, Vivax - epidemiology
/ Malaria, Vivax - parasitology
/ Malaria, Vivax - prevention & control
/ Plasmodium vivax - immunology
/ Plasmodium vivax - pathogenicity
